MPMI (drug)
 | |
| Identifiers | |
|---|---|
IUPAC name
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C14H18N2O2 |
| Molar mass | 246.310 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
3-(N-methylpyrrolidin-3-ylmethyl)indole (MPMI) is a tryptamine drivative which acts as a serotonin receptor agonist. It has been studied as an analogue and trace impurity of the anti-migraine drug eletriptan but is otherwise little known.[1][2]
See also
References
- ↑ FI 105812, Wythes MJ, Macor JE, "Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi", issued 14 April 1993, assigned to Pfizer, Inc.
- ↑ US 5607951, Macor JE, Wythes MJ, "Indole derivatives", issued 4 March 1997, assigned to Pfizer, Inc.
|
| Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.